Drug interactions
Adalimumab + Meningococcal group b vaccine
Severity: Moderate
Adalimumab and Meningococcal group b vaccine: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Adalimumab is a TNF blocker that can blunt the immune response to vaccines, so antibody titres after meningococcal B vaccination may be lower.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Adalimumab and Meningococcal group b vaccine interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Adalimumab
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
